公益財団法人田附興風会 医学研究所北野病院

inquiry
search close
MENU

Departments

Chemotherapy Center (Medical Oncology)

Departments

Medical Departments

Greetings

Features

About treatment

CV port
How to remove the needle yourself

Staff Introduction

化学療法センターベッドルーム

Greetings


Chief Manager Takafumi Nishimura

Kitano Hospital established the Department of Medical Oncology in 2013 with the goal of improving the safety and efficiency of cancer chemotherapy (anti-cancer drug treatment) throughout the hospital and enhancing treatment options. We work in collaboration with all other departments involved in cancer treatment, with the goal of serving all patients receiving anti-cancer drug treatment. While cancer chemotherapy has made remarkable advances in recent years, thanks to various molecular-targeted therapies, including immune checkpoint inhibitors, and new anti-cancer drug combinations, the implementation of increasingly complex and diverse cancer chemotherapy, including treatment selection and side effect management, requires increasingly specialized knowledge and experience. Kitano Hospital's Department of Medical Oncology works in collaboration with the attending physicians in each department, and together with the Chemotherapy Center staff, we strive to ensure that all patients receive the most appropriate anti-cancer drug treatment with peace of mind. We appreciate your continued support.

Characteristics and Initiatives

  1. Chemotherapy outpatient clinic
    We are responsible for outpatient chemotherapy in cooperation with the attending physicians of each department. On the day of treatment, we check blood test results and side effects to take measures and adjust the dosage and schedule of anticancer drugs. We also evaluate the effectiveness of treatment and discuss treatment plans with the attending physicians of each department, and explain the effects and side effects of the next anticancer drug treatment. We also handle telephone consultations (hotline) and emergency consultations if you feel unwell on days other than appointments. We also do our best to accommodate requests for second opinions on chemotherapy from patients undergoing treatment at other hospitals.
  2. Chemotherapy Center Emergency Response
    We have an examination room set up within the chemotherapy center, which is also the treatment room, so we can respond quickly if a patient becomes unwell during treatment. Subsequent treatment plans and measures will also be discussed with the attending physicians of each department.
  3. Consultation
    Even during hospitalization, we will discuss treatment plans together with the patient's attending physicians in each department in response to various consultations regarding chemotherapy.
  4. Development of chemotherapy regimens
    A program that determines how various anti-cancer drugs are administered is called a regimen. When introducing new drugs or new treatments requested by each department, the optimal administration method is considered in consultation with nurses and pharmacists based on clinical trial data and the drug's package insert, and then registered as a regimen.

About treatment

The Department of Medical Oncology works in cooperation with other clinical departments to provide chemotherapy (anticancer drug treatment) mainly for the following cancers:

digestive system
(Digestive Center)		 Esophageal cancer, stomach cancer, colon cancer, pancreatic cancer, biliary tract cancer (bile duct cancer, gallbladder cancer, etc.), liver cancer, neuroendocrine tumors, etc.
respiratory system
(Respiratory Center)		 Lung cancer (non-small cell lung cancer, small cell lung cancer), malignant pleural mesothelioma, thymic cancer, etc.
mammary gland
(Breast surgery)		 Breast cancer
Gynecology
(Obstetrics and Gynecology)		 Ovarian cancer, fallopian tube cancer, peritoneal cancer, uterine cancer (cervical cancer, endometrial cancer), carcinosarcoma, germ cell tumor, trophoblastic tumor, etc.
urinary system
(Urology)		 Urothelial cancer (bladder cancer, ureter cancer, renal pelvis cancer), prostate cancer, kidney cancer, testicular tumors, etc.
Head and neck
(Otolaryngology/Head and Neck Surgery)		 Head and neck squamous cell carcinoma (nasal and paranasal sinus cancer, nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, oral cancer, tongue cancer, etc.), thyroid cancer, etc.
others
(Each clinical department)		 Cancer of unknown primary origin, sarcoma (leiomyosarcoma, synovial sarcoma, etc.), neuroendocrine cancer, etc.

Activity results

Oncology outpatient clinic

Total number of outpatient consultations 6,095 cases (including outpatient care during hospitalization, excluding intravenous port needle removal)
Number of outpatient chemotherapy treatments 2,766 items
Treatment room support 139 items
○ Annual trends
year 2016 2017 2018 2019 2020
Total outpatient consultations* 6,493 6,347 6,311
 5,596
 6,095
Number of outpatient chemotherapy treatments (medical oncology) 2,365 2,292 2,460
 2,348
 2,766

* Includes outpatient care during hospitalization, excluding removal of intravenous port needles

Number of outpatient chemotherapy treatments (all departments)

○Breakdown by medical department
Number of cases performed by each department (including those in the medical oncology department)
Hematology 589 (0)
Respiratory internal medicine 1,518 (1388)
respiratory surgery 330 (63)
Gastroenterology 1,100 (81)
Gastrointestinal surgery 1,492 (741)
breast surgery 1,030 (16)
Obstetrics and Gynecology 420 (97)
Urology 211 (194)
Otolaryngology/Head and Neck Surgery 106 (104)
Neurosurgery 21(0)
Pediatrics 21(0)
Medical Oncology 82
whole 6,759 (2,766)
○Breakdown by medical department

*Velcade subcutaneous injection, bone metastasis treatment drug: does not contain zoledronic acid hydrate.

year 2013 2014 2015 2016 2017
Number of outpatient chemotherapy treatments 5,164 5,868 6,932 7,114 7,123

Number of anti-cancer drug adjustments (chemotherapy premium)

*Except for Zometa injection, Velcade subcutaneous injection, and methotrexate intramuscular injection

whole 10,110 items
Outpatient 6,759 items
hospitalization 3,351 items

Number of outpatient drug explanations provided

218 items

Number of orientations held

390 items

Number of chemotherapy regimens created

Hematology 9 items
respiratory system 7 items
digestive system 19 items
breast surgery 2 items
gynecology 2 items
Urology 3 items
Otolaryngology 1 item
Pediatrics 0 items
dermatology 3 items
Medical Oncology
 1 item
Neurosurgery
 1 item
Nephrology
 2 items
whole 50 items

Business performance (treatment performance, academic societies, publications, research activities, etc.)

Information